High prevalence of chronic kidney disease in Iran: A large population-based study

BMC Public Health

Volumn 9, Issue , 2009, Pages

  Hosseinpanah, Farhad ^a   Kasraei, Farshad ^a   Nassiri, Amir A ^a   Azizi, Fereidoun ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CHRONIC KIDNEY FAILURE; CONFIDENCE INTERVAL; CROSS-SECTIONAL STUDY; FEMALE; GLOMERULUS FILTRATION RATE; HOSPITALIZATION; HUMAN; IRAN; KIDNEY FUNCTION TEST; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; RISK; SEX RATIO; STATISTICAL MODEL; SURVIVAL;

ADULT; AGE DISTRIBUTION; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; IRAN; KIDNEY FUNCTION TESTS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PREVALENCE; RENAL INSUFFICIENCY, CHRONIC; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 62849109317     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-9-44     Document Type: Article

References (40)

1. Atlas of End-Stage Renal Disease in the United States. Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases 2003
2. Prevalence of Chronic Kidney Disease in the United States. J Coresh E Selvin LA Stevens J Manzi JW Kusek P Eggers F Van Lente AS Levey, JAMA 2007 298 17 2038 2047 10.1001/jama.298.17.2038 17986697
3. Chronic kidney disease and cardiovascular disease in the Medicare population. AJ Collins S Li DT Gilbertson J Liu SC Chen CA Herzog, Kidney Int 2003 Suppl 87 S24 S31 10.1046/j.1523-1755.64.s87.5.x
4. Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population. BC Astor H Schmid ER Miller 3rd E Yeung J Coresh, Am J Epidemiol 2008 167 10 1226 1234 10.1093/aje/kwn033 18385206
5. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. DS Keith GA Nichols C Guillion JB Brown DH Smith, Arch Intern Med 2004 164 659 663 10.1001/archinte.164.6.659 15037495
6. Prevalence of high blood pressure and elevated serum creatinine level in the United States: Findings from the third National Health and Nutrition Examination Survey (1988 - 1994). J Coresh GL Wei G McQuillan FL Brancati AS Levey C Jones MJ Klag, Arch Intern Med 2001 161 1207 1216 10.1001/archinte.161. 9.1207 11343443
7. Management of patients with chronic renal insufficiency in the Northeastern United States. AT Kausz SS Khan R Abichandani WH Kazmi GT Obrador R Ruthazer BJ Pereira, J Am Soc Nephrol 2001 12 1501 1507 11423579
8. Early detection and treatment of renal disease in hospitalized diabetic and hypertensive patients: Important differences between practice and published guidelines. WM McClellan DF Knight H Karp WW Brown, Am J Kidney Dis 1997 29 368 375 10.1016/S0272-6386(97)90197-9 9041212
9. Angiotensin-receptor blockade versus convertingenzyme inhibition in type 2 diabetes and nephropathy. AH Barnett SC Bain P Bouter B Karlberg S Madsbad J Jervell J Mustonen, N Engl J Med 2004 351 1952 1961 10.1056/NEJMoa042274 15516696
10. Effect of ACE inhibitors in diabetic and nondiabetic chronic renal disease: a systematic overview of randomized placebo controlled trials. AV Kshirsagar MS Joy SL Hogan RJ Falk RE Colindres, AM J Kidney Dis 2000 35 695 707 10.1016/S0272-6386(00)70018-7 10739792
11. Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. TH Jafar CH Schmid M Landa I Giatras R Toto G Remuzzi G Maschio BM Brenner A Kamper P Zucchelli G Becker A Himmelmann K Bannister, Ann Intern Med 2001 135 73 87 11453706
12. Prevalence of Kidney Damage in Australian Adults: The AusDiab Kidney Study. SJ Chadban E Briganti PG Kerr DW Dunstan TA Welborn PZ Zimmet RC Atkins, J Am Soc Nephrol 2003 14 S131 S138 10.1097/01.ASN.0000070152.11927.4A 12819318
13. Prevalence of chronic kidney disease (CKD) in the Japanese general population predicted by the MDRD equation modified by a Japanese coefficient. E Imai M Horio K Iseki K Yamagata T Watanabe S Hara N Ura Y Kiyohara H Hirakata, Clin Exp Nephrol 2007 11 156 163 10.1007/s10157-007-0463-x 17593516
14. Risks factors for proteinuria in a large, multiracial southeast Asian population. SPB Ramirez W Mcclellan FK Port SH Hsu, J Am Soc Nephrol 2002 13 1907 1917 10.1097/01.ASN.0000018406.20282.C8 12089388
15. Chronic kidney disease as a global public health problem: Approaches and initiatives - a position statement from kidney Disease Improving Global Outcomes. AS Levey R Atkins J Coresh EP Cohen AJ Collins KU Eckardt ME Nahas BL Jaber M Jadoul A Levin NR Powe J Rossert DC Wheeler N Lameire G Eknoyan, Kidney Int 2007 72 3 247 259 10.1038/sj.ki.5002343 17568785
16. Tobacco, hypertension, and vascular disease: risk factors for renal functional decline in an older population. AJ Bleyer LR Shemanski GL Burke KJ Hansen RG Appel, Kidney Int 2000 57 2072 2079 10.1046/j.1523-1755.2000.00056.x 10792626
17. Smoking is associated with renal impairment and proteinuria in the normal population: the AusDiab Kidney Study. EM Briganti P Branley SJ Chadban JE Shaw JJ McNeil TA Welborn RC Atkins, Am J Kidney Dis 2002 40 704 712 10.1053/ajkd.2002.35677 12324904
18. Predictors of New-Onset Kidney Disease in a Community-Based Population. CS Fox MG Larson EP Leip B Culleton PWF Wilson D Levy, JAMA 2004 291 844 850 10.1001/jama.291.7.844 14970063
19. Risk factors for chronic kidney disease: a prospective study of 23,534 men and women in Washington County, Maryland. MK Haroun BG Jaar SC Hoffman GW Comstock MJ Klag J Coresh, J Am Soc Nephrol 2003 14 2934 2941 10.1097/01.ASN.0000095249.99803.85 14569104
20. Body mass index and the risk of development of end-stage renal disease in a screened cohort. K Iseki, Kidney Int 2004 65 1870 1876 10.1111/j.1523-1755. 2004.00582.x 15086929
21. Hyperlipidemia in patients with chronic renal disease. BL Kasiske, Am J Kidney Dis 1998 32 suppl 3 S142 S156 10.1053/ajkd.1998.v32.pm9820472
22. Blood pressure and end-stage renal disease in men. MJ Klag PK Whelton BL Randall JD Neaton FL Brancati, N Engl J Med 1996 334 13 18 10.1056/ NEJM199601043340103 7494564
23. Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. P Muntner J Coresh JC SMITH J Eckfeldt MJ Klag, Kidney Int 2000 58 293 301 10.1046/j.1523-1755.2000.00165.x 10886574
24. Influence of smoking and obesity on the development of proteinuria. M Tozawa K Iseki S Oshiro Y Ikemiya S Takishita, Kidney Int 2002 62 956 962 10.1046/j.1523-1755.2002.00506.x 12164878
25. Tehran Lipid and Glucose Study. F Azizi M Rahmani H Emami M Madjid, CVD Prevention 2000 3 242 247
26. Cardiovascular risk factors in an Iranian urban population: Tehran lipid and glucose study (phase 1). F Azizi M Rahmani H Emami P Mirmiran R Hajipour M Madjid J Ghanbili A Ghanbarian Y Mehrabi N Saadat P Salehi N Mortazavi P Heydarian N Sarbazi S Allahverdian N Saadati E Ainy S Moeini, Soz Praventivmed 2002 47 6 408 26 12643001
27. Diabetes Mellitus: Report of a WHO Study Group. World Health Organization, World Health Organ Tech Rep Ser 1985 727 1 113 3934850
28. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Kidney Disease Outcome Quality Initiative. Am J Kidney Dis 2002 39 2 Suppl 1 S1 246 11904577
29. A simplified equation to predict glomerular filtration rate from serum creatinine. [abstract]. AS Levey T Green J Kusek GJ Beck MS Group, J Am Soc Nephrol 2000 11 0828A
30. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001 285 19 2486 2497 11368702 10.1001/jama.285.19.2486
31. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC7). AV Chobanian GL Bakris HR Black WC Cushman LA Green JL Izzo DW Jones BJ Materson S Oparil JT Wright EJ Roccella at NHBPEPCC, Hypertension 2003 42 1206 1252 10.1161/01.HYP.0000107251. 49515.c2 14656957
32. Prevalence of Chronic Kidney Disease and Decreased Kidney Function in the Adult US Population: Third National Health and Nutrition Examination Survey. J Coresh BC Astor T Greene G Eknoyan AS Levey, Am J Kidney Dis 2003 41 1 1 12 10.1053/ajkd.2003.50007 12500213
33. International Comparison of the Relationship of Chronic Kidney Disease Prevalence and ESRD Risk. SI Hallan J Coresh BC Astor A Sberg NR Powe S Romundstad HA Hallan S Lydersen J Holmen, J Am Soc Nephrol 2006 17 2275 2284 10.1681/ASN.2005121273 16790511
34. Prevalence of decreased kidney function in Chinese adults aged 35 to 75 years. J Chen, Kidney Int 2005 68 2837 2845 10.1111/j.1523-1755.2005.00757.x 16316361
35. Serum Creatinine as Marker of Kidney Function in South Asians: A Study of Reduced GFR in Adults in Pakistan. TH Jafar CH Schmid AS Levey, J Am Soc Nephrol 2005 16 1413 1419 10.1681/ASN.2004121100 15800118
36. High prevalence of chronic kidney disease in Thailand. V Perkovic A Cass AA Patel P Suriyawongpaisal F Barzi S Chadban S MacMahon B Neal on behalf of the InterASIA Collaborative Group, Kidney Int 2008 73 473 479 10.1038/sj.ki.5002701 18059458
37. Prevalence and Factors Associated With CKD: A Population Study From Beijing. L Zhang P Zhang F Wang L Zuo Y Zhou Y Shi G Li S Jiao Z Liu W Liang HY Wang, Am J Kidney Dis 2008 51 3 373 384 10.1053/j.ajkd.2007.11.009 18295053
38. Why the MDRD equation should not be used in patients with normal renal function (and normal creatinine values). P Delanaye E Cavalier JM Krzesinski, Clin Nephrol 2006 66 2 147 148 16939074
39. Overview: Obesity: What Does It Have to Do with Kidney Disease? CK Abrass, J Am Soc Nephrol 2004 15 2768 2772 10.1097/01.ASN.0000141963.04540.3E 15504929
40. Glycemic Status and Development of Kidney Disease. CS Fox MG Larson EP Leip JB Meigs PWF Wilson D Levy, Diabetes Care 2005 28 2436 2440 10.2337/diacare.28.10.2436 16186276